Zum Inhalt springen Zur Suche springen

News-Detail

The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant.
Emilie Le Rhun et al., Neuro Oncol. 2025

Emilie Le Rhun, Andrea Bink, Joerg Felsberg, Dorothee Gramatzki, Sebastian Brandner, Jamal K Benhamida, Antje Wick, Joerg C Tonn, Malte Mohme, Ghazaleh Tabatabai, David Capper, Matija Snuderl, Evangelia Razis, Michael W Ronellenfitsch, Nicolas Neidert, Ho-Keung Ng, Ute Pohl, Tejus Bale, Stefanie Quach, David Rieger, Ulrich Schüller, Julia Onken, Katharina Drüschler, Claude-Alain Maurage, Luca Regli, Estelle Healy, Maya Graham, Tibor Hortobagyi, Simon Paine, Leslie Bridges, Tereza Lausova, Valentina Medici, Philipp Sievers, David Schrimpf, Wolfgang Wick, Felix Sahm, Guido Reifenberger, Andreas von Deimling, Michael Weller; H3 G34 DHG Study Group.

The clinical and molecular landscape of diffuse hemispheric glioma, H3 G34-mutant.

Neuro Oncol. 2025 Jul 30;27(6):1519-1535. doi: 10.1093/neuonc/noaf015. PubMed ID: 39842935

 

Further Information:

DOI: 10.1093/neuonc/noaf015

Guido Reifenberger

Kategorie/n: NND-Publikationen